ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Berlex Laboratories


Include trials that are no longer recruiting patients.

5 studies were found.
1.RecruitingCampath-1H Plus Rituximab for CD52- and CD20- Positive Refractory or Relapsed Chronic Lymphoid Disorders
Condition: Chronic Lymphocytic Leukemia
2.CompletedComparison of efficacy and safety of Azelaic Acid 15% gel with its vehicle in subjects with mild to moderate acne.
Condition: Acne
3.RecruitingFludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
4.CompletedPhase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen
Condition: HIV Infections
5.RecruitingSpheramine® in advanced Parkinson’s disease (The STEPS Trial)
Condition: Parkinson Disease

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act